JAMA Network Open-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2261492, encodeId=a0f4226149232, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：难啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d899606138, createdName=ms6000000839895533, createdTime=Tue Apr 22 00:22:39 CST 2025, time=2025-04-22, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2259521, encodeId=4c842259521f5, content=拒稿 Start Date Review Complete - Decision Processed 04-07-2025 09:27 Under Review 03-31-2025 14:41 In Quality Control 03-31-2025 09:20 Submission Pending 03-30-2025 23:00, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0c7a5682566, createdName=ms1000001393535737, createdTime=Mon Apr 07 22:29:10 CST 2025, time=2025-04-07, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2254004, encodeId=09b122540047c, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：健康公平 经验分享：焦急等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97486435543, createdName=1057541_1346, createdTime=Fri Feb 28 12:17:25 CST 2025, time=2025-02-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2257627, encodeId=5141225e6274b, content=偏重的研究方向：公共卫生;运动康复 经验分享：In Quality Control 3.24 Under Review 3.25, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34be9276683, createdName=ms8000000722006726, createdTime=Tue Mar 25 10:53:00 CST 2025, time=2025-03-25, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2254908, encodeId=f47b225490846, content=问一下投过的大神们，外科的东西能投这个刊吗？不知道投jama surgery还是这个好中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=618e8608174, createdName=ms4000001428066077, createdTime=Thu Mar 06 18:18:42 CST 2025, time=2025-03-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2230384, encodeId=e1ca223038479, content=偏重的研究方向：公共卫生 经验分享：10-7 submission pending, in quality control, under review 感觉自己写的很差，开个帖记录一下多久会被拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea339149238, createdName=ms7000000384438036, createdTime=Fri Oct 11 20:37:08 CST 2024, time=2024-10-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1231654, encodeId=02ab1231654ab, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：We agree to consider your manuscript with the understanding that its content, figures, and tables have not been published or submitted elsewhere in print or electronic format and will not be submitted elsewhere during the period of review by JAMA Network Open. 这个邮件发过来是送外审的意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=615, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=66e85489884, createdName=ms6000000512079400, createdTime=Sun Jul 10 15:33:48 CST 2022, time=2022-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2237621, encodeId=364e223e621d2, content=偏重的研究方向：公共卫生 经验分享：记录一下 In Quality Control 11-03-2024 Under Review 11-14-2024 Review Complete - Decision Processed 11-15-2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00ca9170328, createdName=ms9000001085107463, createdTime=Mon Nov 18 16:36:31 CST 2024, time=2024-11-18, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=971239, encodeId=7dd09e1239e2, content=在jama c a r d iol o g y子刊上投了一篇，很快拒稿然后根据我的要求转投ja ma network op en杂志，希望有好结果！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=953, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IRJ7eO6DmdWicRgxO6ka2BZ4CAeEMy8ZKWIfz7TDKA1ibzKutMicHN8E6o9wZGE0dN4R5uK3cyHbpWCiatxSqeSNTQ/132, createdBy=eaca1651997, createdName=1ddccb01m45(暂无匿称), createdTime=Sun Jun 06 07:04:36 CST 2021, time=2021-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236390, encodeId=f7111236390f0, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科 经验分享：最近刚接收一篇，审稿周期2月，审稿意见也很专业，对统计方面要求很高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=870, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/55fdd2926f3844a58e02901f47326051/cd164ae797d549e8b5cdc9ed790bc1b5.jpg, createdBy=59502040784, createdName=sur_wu, createdTime=Wed Aug 03 16:43:41 CST 2022, time=2022-08-03, status=1, ipAttribution=)]

2025-04-22 ms6000000839895533 来自加利福尼亚

审稿速度:24.0 | 投稿命中率:25.0
经验分享：难啊

4 0

[GetPortalCommentsPageByObjectIdResponse(id=2261492, encodeId=a0f4226149232, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：难啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d899606138, createdName=ms6000000839895533, createdTime=Tue Apr 22 00:22:39 CST 2025, time=2025-04-22, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2259521, encodeId=4c842259521f5, content=拒稿 Start Date Review Complete - Decision Processed 04-07-2025 09:27 Under Review 03-31-2025 14:41 In Quality Control 03-31-2025 09:20 Submission Pending 03-30-2025 23:00, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0c7a5682566, createdName=ms1000001393535737, createdTime=Mon Apr 07 22:29:10 CST 2025, time=2025-04-07, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2254004, encodeId=09b122540047c, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：健康公平 经验分享：焦急等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97486435543, createdName=1057541_1346, createdTime=Fri Feb 28 12:17:25 CST 2025, time=2025-02-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2257627, encodeId=5141225e6274b, content=偏重的研究方向：公共卫生;运动康复 经验分享：In Quality Control 3.24 Under Review 3.25, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34be9276683, createdName=ms8000000722006726, createdTime=Tue Mar 25 10:53:00 CST 2025, time=2025-03-25, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2254908, encodeId=f47b225490846, content=问一下投过的大神们，外科的东西能投这个刊吗？不知道投jama surgery还是这个好中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=618e8608174, createdName=ms4000001428066077, createdTime=Thu Mar 06 18:18:42 CST 2025, time=2025-03-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2230384, encodeId=e1ca223038479, content=偏重的研究方向：公共卫生 经验分享：10-7 submission pending, in quality control, under review 感觉自己写的很差，开个帖记录一下多久会被拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea339149238, createdName=ms7000000384438036, createdTime=Fri Oct 11 20:37:08 CST 2024, time=2024-10-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1231654, encodeId=02ab1231654ab, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：We agree to consider your manuscript with the understanding that its content, figures, and tables have not been published or submitted elsewhere in print or electronic format and will not be submitted elsewhere during the period of review by JAMA Network Open. 这个邮件发过来是送外审的意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=615, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=66e85489884, createdName=ms6000000512079400, createdTime=Sun Jul 10 15:33:48 CST 2022, time=2022-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2237621, encodeId=364e223e621d2, content=偏重的研究方向：公共卫生 经验分享：记录一下 In Quality Control 11-03-2024 Under Review 11-14-2024 Review Complete - Decision Processed 11-15-2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00ca9170328, createdName=ms9000001085107463, createdTime=Mon Nov 18 16:36:31 CST 2024, time=2024-11-18, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=971239, encodeId=7dd09e1239e2, content=在jama c a r d iol o g y子刊上投了一篇，很快拒稿然后根据我的要求转投ja ma network op en杂志，希望有好结果！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=953, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IRJ7eO6DmdWicRgxO6ka2BZ4CAeEMy8ZKWIfz7TDKA1ibzKutMicHN8E6o9wZGE0dN4R5uK3cyHbpWCiatxSqeSNTQ/132, createdBy=eaca1651997, createdName=1ddccb01m45(暂无匿称), createdTime=Sun Jun 06 07:04:36 CST 2021, time=2021-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236390, encodeId=f7111236390f0, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科 经验分享：最近刚接收一篇，审稿周期2月，审稿意见也很专业，对统计方面要求很高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=870, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/55fdd2926f3844a58e02901f47326051/cd164ae797d549e8b5cdc9ed790bc1b5.jpg, createdBy=59502040784, createdName=sur_wu, createdTime=Wed Aug 03 16:43:41 CST 2022, time=2022-08-03, status=1, ipAttribution=)]

2025-04-07 ms1000001393535737 来自湖北省

拒稿
Start Date
Review Complete - Decision Processed 04-07-2025 09:27
Under Review 03-31-2025 14:41
In Quality Control 03-31-2025 09:20
Submission Pending 03-30-2025 23:00

13 0

[GetPortalCommentsPageByObjectIdResponse(id=2261492, encodeId=a0f4226149232, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：难啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d899606138, createdName=ms6000000839895533, createdTime=Tue Apr 22 00:22:39 CST 2025, time=2025-04-22, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2259521, encodeId=4c842259521f5, content=拒稿 Start Date Review Complete - Decision Processed 04-07-2025 09:27 Under Review 03-31-2025 14:41 In Quality Control 03-31-2025 09:20 Submission Pending 03-30-2025 23:00, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0c7a5682566, createdName=ms1000001393535737, createdTime=Mon Apr 07 22:29:10 CST 2025, time=2025-04-07, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2254004, encodeId=09b122540047c, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：健康公平 经验分享：焦急等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97486435543, createdName=1057541_1346, createdTime=Fri Feb 28 12:17:25 CST 2025, time=2025-02-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2257627, encodeId=5141225e6274b, content=偏重的研究方向：公共卫生;运动康复 经验分享：In Quality Control 3.24 Under Review 3.25, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34be9276683, createdName=ms8000000722006726, createdTime=Tue Mar 25 10:53:00 CST 2025, time=2025-03-25, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2254908, encodeId=f47b225490846, content=问一下投过的大神们，外科的东西能投这个刊吗？不知道投jama surgery还是这个好中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=618e8608174, createdName=ms4000001428066077, createdTime=Thu Mar 06 18:18:42 CST 2025, time=2025-03-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2230384, encodeId=e1ca223038479, content=偏重的研究方向：公共卫生 经验分享：10-7 submission pending, in quality control, under review 感觉自己写的很差，开个帖记录一下多久会被拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea339149238, createdName=ms7000000384438036, createdTime=Fri Oct 11 20:37:08 CST 2024, time=2024-10-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1231654, encodeId=02ab1231654ab, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：We agree to consider your manuscript with the understanding that its content, figures, and tables have not been published or submitted elsewhere in print or electronic format and will not be submitted elsewhere during the period of review by JAMA Network Open. 这个邮件发过来是送外审的意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=615, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=66e85489884, createdName=ms6000000512079400, createdTime=Sun Jul 10 15:33:48 CST 2022, time=2022-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2237621, encodeId=364e223e621d2, content=偏重的研究方向：公共卫生 经验分享：记录一下 In Quality Control 11-03-2024 Under Review 11-14-2024 Review Complete - Decision Processed 11-15-2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00ca9170328, createdName=ms9000001085107463, createdTime=Mon Nov 18 16:36:31 CST 2024, time=2024-11-18, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=971239, encodeId=7dd09e1239e2, content=在jama c a r d iol o g y子刊上投了一篇，很快拒稿然后根据我的要求转投ja ma network op en杂志，希望有好结果！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=953, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IRJ7eO6DmdWicRgxO6ka2BZ4CAeEMy8ZKWIfz7TDKA1ibzKutMicHN8E6o9wZGE0dN4R5uK3cyHbpWCiatxSqeSNTQ/132, createdBy=eaca1651997, createdName=1ddccb01m45(暂无匿称), createdTime=Sun Jun 06 07:04:36 CST 2021, time=2021-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236390, encodeId=f7111236390f0, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科 经验分享：最近刚接收一篇，审稿周期2月，审稿意见也很专业，对统计方面要求很高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=870, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/55fdd2926f3844a58e02901f47326051/cd164ae797d549e8b5cdc9ed790bc1b5.jpg, createdBy=59502040784, createdName=sur_wu, createdTime=Wed Aug 03 16:43:41 CST 2022, time=2022-08-03, status=1, ipAttribution=)]

2025-02-28 1057541_1346 来自上海

审稿速度:2.0 | 投稿命中率:5.0
偏重的研究方向：健康公平
经验分享：焦急等待中

20 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2261492, encodeId=a0f4226149232, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：难啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d899606138, createdName=ms6000000839895533, createdTime=Tue Apr 22 00:22:39 CST 2025, time=2025-04-22, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2259521, encodeId=4c842259521f5, content=拒稿 Start Date Review Complete - Decision Processed 04-07-2025 09:27 Under Review 03-31-2025 14:41 In Quality Control 03-31-2025 09:20 Submission Pending 03-30-2025 23:00, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0c7a5682566, createdName=ms1000001393535737, createdTime=Mon Apr 07 22:29:10 CST 2025, time=2025-04-07, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2254004, encodeId=09b122540047c, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：健康公平 经验分享：焦急等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97486435543, createdName=1057541_1346, createdTime=Fri Feb 28 12:17:25 CST 2025, time=2025-02-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2257627, encodeId=5141225e6274b, content=偏重的研究方向：公共卫生;运动康复 经验分享：In Quality Control 3.24 Under Review 3.25, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34be9276683, createdName=ms8000000722006726, createdTime=Tue Mar 25 10:53:00 CST 2025, time=2025-03-25, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2254908, encodeId=f47b225490846, content=问一下投过的大神们，外科的东西能投这个刊吗？不知道投jama surgery还是这个好中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=618e8608174, createdName=ms4000001428066077, createdTime=Thu Mar 06 18:18:42 CST 2025, time=2025-03-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2230384, encodeId=e1ca223038479, content=偏重的研究方向：公共卫生 经验分享：10-7 submission pending, in quality control, under review 感觉自己写的很差，开个帖记录一下多久会被拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea339149238, createdName=ms7000000384438036, createdTime=Fri Oct 11 20:37:08 CST 2024, time=2024-10-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1231654, encodeId=02ab1231654ab, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：We agree to consider your manuscript with the understanding that its content, figures, and tables have not been published or submitted elsewhere in print or electronic format and will not be submitted elsewhere during the period of review by JAMA Network Open. 这个邮件发过来是送外审的意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=615, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=66e85489884, createdName=ms6000000512079400, createdTime=Sun Jul 10 15:33:48 CST 2022, time=2022-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2237621, encodeId=364e223e621d2, content=偏重的研究方向：公共卫生 经验分享：记录一下 In Quality Control 11-03-2024 Under Review 11-14-2024 Review Complete - Decision Processed 11-15-2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00ca9170328, createdName=ms9000001085107463, createdTime=Mon Nov 18 16:36:31 CST 2024, time=2024-11-18, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=971239, encodeId=7dd09e1239e2, content=在jama c a r d iol o g y子刊上投了一篇，很快拒稿然后根据我的要求转投ja ma network op en杂志，希望有好结果！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=953, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IRJ7eO6DmdWicRgxO6ka2BZ4CAeEMy8ZKWIfz7TDKA1ibzKutMicHN8E6o9wZGE0dN4R5uK3cyHbpWCiatxSqeSNTQ/132, createdBy=eaca1651997, createdName=1ddccb01m45(暂无匿称), createdTime=Sun Jun 06 07:04:36 CST 2021, time=2021-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236390, encodeId=f7111236390f0, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科 经验分享：最近刚接收一篇，审稿周期2月，审稿意见也很专业，对统计方面要求很高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=870, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/55fdd2926f3844a58e02901f47326051/cd164ae797d549e8b5cdc9ed790bc1b5.jpg, createdBy=59502040784, createdName=sur_wu, createdTime=Wed Aug 03 16:43:41 CST 2022, time=2022-08-03, status=1, ipAttribution=)]

2025-03-25 ms8000000722006726 来自江西省

偏重的研究方向：公共卫生;运动康复
经验分享：In Quality Control 3.24
Under Review 3.25

13 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2261492, encodeId=a0f4226149232, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：难啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d899606138, createdName=ms6000000839895533, createdTime=Tue Apr 22 00:22:39 CST 2025, time=2025-04-22, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2259521, encodeId=4c842259521f5, content=拒稿 Start Date Review Complete - Decision Processed 04-07-2025 09:27 Under Review 03-31-2025 14:41 In Quality Control 03-31-2025 09:20 Submission Pending 03-30-2025 23:00, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0c7a5682566, createdName=ms1000001393535737, createdTime=Mon Apr 07 22:29:10 CST 2025, time=2025-04-07, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2254004, encodeId=09b122540047c, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：健康公平 经验分享：焦急等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97486435543, createdName=1057541_1346, createdTime=Fri Feb 28 12:17:25 CST 2025, time=2025-02-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2257627, encodeId=5141225e6274b, content=偏重的研究方向：公共卫生;运动康复 经验分享：In Quality Control 3.24 Under Review 3.25, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34be9276683, createdName=ms8000000722006726, createdTime=Tue Mar 25 10:53:00 CST 2025, time=2025-03-25, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2254908, encodeId=f47b225490846, content=问一下投过的大神们，外科的东西能投这个刊吗？不知道投jama surgery还是这个好中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=618e8608174, createdName=ms4000001428066077, createdTime=Thu Mar 06 18:18:42 CST 2025, time=2025-03-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2230384, encodeId=e1ca223038479, content=偏重的研究方向：公共卫生 经验分享：10-7 submission pending, in quality control, under review 感觉自己写的很差，开个帖记录一下多久会被拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea339149238, createdName=ms7000000384438036, createdTime=Fri Oct 11 20:37:08 CST 2024, time=2024-10-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1231654, encodeId=02ab1231654ab, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：We agree to consider your manuscript with the understanding that its content, figures, and tables have not been published or submitted elsewhere in print or electronic format and will not be submitted elsewhere during the period of review by JAMA Network Open. 这个邮件发过来是送外审的意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=615, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=66e85489884, createdName=ms6000000512079400, createdTime=Sun Jul 10 15:33:48 CST 2022, time=2022-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2237621, encodeId=364e223e621d2, content=偏重的研究方向：公共卫生 经验分享：记录一下 In Quality Control 11-03-2024 Under Review 11-14-2024 Review Complete - Decision Processed 11-15-2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00ca9170328, createdName=ms9000001085107463, createdTime=Mon Nov 18 16:36:31 CST 2024, time=2024-11-18, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=971239, encodeId=7dd09e1239e2, content=在jama c a r d iol o g y子刊上投了一篇，很快拒稿然后根据我的要求转投ja ma network op en杂志，希望有好结果！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=953, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IRJ7eO6DmdWicRgxO6ka2BZ4CAeEMy8ZKWIfz7TDKA1ibzKutMicHN8E6o9wZGE0dN4R5uK3cyHbpWCiatxSqeSNTQ/132, createdBy=eaca1651997, createdName=1ddccb01m45(暂无匿称), createdTime=Sun Jun 06 07:04:36 CST 2021, time=2021-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236390, encodeId=f7111236390f0, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科 经验分享：最近刚接收一篇，审稿周期2月，审稿意见也很专业，对统计方面要求很高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=870, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/55fdd2926f3844a58e02901f47326051/cd164ae797d549e8b5cdc9ed790bc1b5.jpg, createdBy=59502040784, createdName=sur_wu, createdTime=Wed Aug 03 16:43:41 CST 2022, time=2022-08-03, status=1, ipAttribution=)]

2025-03-06 ms4000001428066077 来自北京

问一下投过的大神们，外科的东西能投这个刊吗？不知道投jama surgery还是这个好中

20 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2261492, encodeId=a0f4226149232, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：难啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d899606138, createdName=ms6000000839895533, createdTime=Tue Apr 22 00:22:39 CST 2025, time=2025-04-22, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2259521, encodeId=4c842259521f5, content=拒稿 Start Date Review Complete - Decision Processed 04-07-2025 09:27 Under Review 03-31-2025 14:41 In Quality Control 03-31-2025 09:20 Submission Pending 03-30-2025 23:00, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0c7a5682566, createdName=ms1000001393535737, createdTime=Mon Apr 07 22:29:10 CST 2025, time=2025-04-07, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2254004, encodeId=09b122540047c, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：健康公平 经验分享：焦急等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97486435543, createdName=1057541_1346, createdTime=Fri Feb 28 12:17:25 CST 2025, time=2025-02-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2257627, encodeId=5141225e6274b, content=偏重的研究方向：公共卫生;运动康复 经验分享：In Quality Control 3.24 Under Review 3.25, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34be9276683, createdName=ms8000000722006726, createdTime=Tue Mar 25 10:53:00 CST 2025, time=2025-03-25, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2254908, encodeId=f47b225490846, content=问一下投过的大神们，外科的东西能投这个刊吗？不知道投jama surgery还是这个好中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=618e8608174, createdName=ms4000001428066077, createdTime=Thu Mar 06 18:18:42 CST 2025, time=2025-03-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2230384, encodeId=e1ca223038479, content=偏重的研究方向：公共卫生 经验分享：10-7 submission pending, in quality control, under review 感觉自己写的很差，开个帖记录一下多久会被拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea339149238, createdName=ms7000000384438036, createdTime=Fri Oct 11 20:37:08 CST 2024, time=2024-10-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1231654, encodeId=02ab1231654ab, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：We agree to consider your manuscript with the understanding that its content, figures, and tables have not been published or submitted elsewhere in print or electronic format and will not be submitted elsewhere during the period of review by JAMA Network Open. 这个邮件发过来是送外审的意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=615, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=66e85489884, createdName=ms6000000512079400, createdTime=Sun Jul 10 15:33:48 CST 2022, time=2022-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2237621, encodeId=364e223e621d2, content=偏重的研究方向：公共卫生 经验分享：记录一下 In Quality Control 11-03-2024 Under Review 11-14-2024 Review Complete - Decision Processed 11-15-2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00ca9170328, createdName=ms9000001085107463, createdTime=Mon Nov 18 16:36:31 CST 2024, time=2024-11-18, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=971239, encodeId=7dd09e1239e2, content=在jama c a r d iol o g y子刊上投了一篇，很快拒稿然后根据我的要求转投ja ma network op en杂志，希望有好结果！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=953, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IRJ7eO6DmdWicRgxO6ka2BZ4CAeEMy8ZKWIfz7TDKA1ibzKutMicHN8E6o9wZGE0dN4R5uK3cyHbpWCiatxSqeSNTQ/132, createdBy=eaca1651997, createdName=1ddccb01m45(暂无匿称), createdTime=Sun Jun 06 07:04:36 CST 2021, time=2021-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236390, encodeId=f7111236390f0, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科 经验分享：最近刚接收一篇，审稿周期2月，审稿意见也很专业，对统计方面要求很高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=870, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/55fdd2926f3844a58e02901f47326051/cd164ae797d549e8b5cdc9ed790bc1b5.jpg, createdBy=59502040784, createdName=sur_wu, createdTime=Wed Aug 03 16:43:41 CST 2022, time=2022-08-03, status=1, ipAttribution=)]

2024-10-11 ms7000000384438036 来自山东省

偏重的研究方向：公共卫生
经验分享：10-7 submission pending, in quality control, under review
感觉自己写的很差，开个帖记录一下多久会被拒稿

76 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2261492, encodeId=a0f4226149232, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：难啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d899606138, createdName=ms6000000839895533, createdTime=Tue Apr 22 00:22:39 CST 2025, time=2025-04-22, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2259521, encodeId=4c842259521f5, content=拒稿 Start Date Review Complete - Decision Processed 04-07-2025 09:27 Under Review 03-31-2025 14:41 In Quality Control 03-31-2025 09:20 Submission Pending 03-30-2025 23:00, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0c7a5682566, createdName=ms1000001393535737, createdTime=Mon Apr 07 22:29:10 CST 2025, time=2025-04-07, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2254004, encodeId=09b122540047c, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：健康公平 经验分享：焦急等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97486435543, createdName=1057541_1346, createdTime=Fri Feb 28 12:17:25 CST 2025, time=2025-02-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2257627, encodeId=5141225e6274b, content=偏重的研究方向：公共卫生;运动康复 经验分享：In Quality Control 3.24 Under Review 3.25, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34be9276683, createdName=ms8000000722006726, createdTime=Tue Mar 25 10:53:00 CST 2025, time=2025-03-25, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2254908, encodeId=f47b225490846, content=问一下投过的大神们，外科的东西能投这个刊吗？不知道投jama surgery还是这个好中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=618e8608174, createdName=ms4000001428066077, createdTime=Thu Mar 06 18:18:42 CST 2025, time=2025-03-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2230384, encodeId=e1ca223038479, content=偏重的研究方向：公共卫生 经验分享：10-7 submission pending, in quality control, under review 感觉自己写的很差，开个帖记录一下多久会被拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea339149238, createdName=ms7000000384438036, createdTime=Fri Oct 11 20:37:08 CST 2024, time=2024-10-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1231654, encodeId=02ab1231654ab, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：We agree to consider your manuscript with the understanding that its content, figures, and tables have not been published or submitted elsewhere in print or electronic format and will not be submitted elsewhere during the period of review by JAMA Network Open. 这个邮件发过来是送外审的意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=615, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=66e85489884, createdName=ms6000000512079400, createdTime=Sun Jul 10 15:33:48 CST 2022, time=2022-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2237621, encodeId=364e223e621d2, content=偏重的研究方向：公共卫生 经验分享：记录一下 In Quality Control 11-03-2024 Under Review 11-14-2024 Review Complete - Decision Processed 11-15-2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00ca9170328, createdName=ms9000001085107463, createdTime=Mon Nov 18 16:36:31 CST 2024, time=2024-11-18, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=971239, encodeId=7dd09e1239e2, content=在jama c a r d iol o g y子刊上投了一篇，很快拒稿然后根据我的要求转投ja ma network op en杂志，希望有好结果！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=953, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IRJ7eO6DmdWicRgxO6ka2BZ4CAeEMy8ZKWIfz7TDKA1ibzKutMicHN8E6o9wZGE0dN4R5uK3cyHbpWCiatxSqeSNTQ/132, createdBy=eaca1651997, createdName=1ddccb01m45(暂无匿称), createdTime=Sun Jun 06 07:04:36 CST 2021, time=2021-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236390, encodeId=f7111236390f0, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科 经验分享：最近刚接收一篇，审稿周期2月，审稿意见也很专业，对统计方面要求很高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=870, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/55fdd2926f3844a58e02901f47326051/cd164ae797d549e8b5cdc9ed790bc1b5.jpg, createdBy=59502040784, createdName=sur_wu, createdTime=Wed Aug 03 16:43:41 CST 2022, time=2022-08-03, status=1, ipAttribution=)]

2022-07-10 ms6000000512079400

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：肿瘤
经验分享：We agree to consider your manuscript with the understanding that its content, figures, and tables have not been published or submitted elsewhere in print or electronic format and will not be submitted elsewhere during the period of review by JAMA Network Open. 这个邮件发过来是送外审的意思吗

615 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2261492, encodeId=a0f4226149232, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：难啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d899606138, createdName=ms6000000839895533, createdTime=Tue Apr 22 00:22:39 CST 2025, time=2025-04-22, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2259521, encodeId=4c842259521f5, content=拒稿 Start Date Review Complete - Decision Processed 04-07-2025 09:27 Under Review 03-31-2025 14:41 In Quality Control 03-31-2025 09:20 Submission Pending 03-30-2025 23:00, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0c7a5682566, createdName=ms1000001393535737, createdTime=Mon Apr 07 22:29:10 CST 2025, time=2025-04-07, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2254004, encodeId=09b122540047c, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：健康公平 经验分享：焦急等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97486435543, createdName=1057541_1346, createdTime=Fri Feb 28 12:17:25 CST 2025, time=2025-02-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2257627, encodeId=5141225e6274b, content=偏重的研究方向：公共卫生;运动康复 经验分享：In Quality Control 3.24 Under Review 3.25, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34be9276683, createdName=ms8000000722006726, createdTime=Tue Mar 25 10:53:00 CST 2025, time=2025-03-25, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2254908, encodeId=f47b225490846, content=问一下投过的大神们，外科的东西能投这个刊吗？不知道投jama surgery还是这个好中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=618e8608174, createdName=ms4000001428066077, createdTime=Thu Mar 06 18:18:42 CST 2025, time=2025-03-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2230384, encodeId=e1ca223038479, content=偏重的研究方向：公共卫生 经验分享：10-7 submission pending, in quality control, under review 感觉自己写的很差，开个帖记录一下多久会被拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea339149238, createdName=ms7000000384438036, createdTime=Fri Oct 11 20:37:08 CST 2024, time=2024-10-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1231654, encodeId=02ab1231654ab, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：We agree to consider your manuscript with the understanding that its content, figures, and tables have not been published or submitted elsewhere in print or electronic format and will not be submitted elsewhere during the period of review by JAMA Network Open. 这个邮件发过来是送外审的意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=615, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=66e85489884, createdName=ms6000000512079400, createdTime=Sun Jul 10 15:33:48 CST 2022, time=2022-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2237621, encodeId=364e223e621d2, content=偏重的研究方向：公共卫生 经验分享：记录一下 In Quality Control 11-03-2024 Under Review 11-14-2024 Review Complete - Decision Processed 11-15-2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00ca9170328, createdName=ms9000001085107463, createdTime=Mon Nov 18 16:36:31 CST 2024, time=2024-11-18, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=971239, encodeId=7dd09e1239e2, content=在jama c a r d iol o g y子刊上投了一篇，很快拒稿然后根据我的要求转投ja ma network op en杂志，希望有好结果！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=953, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IRJ7eO6DmdWicRgxO6ka2BZ4CAeEMy8ZKWIfz7TDKA1ibzKutMicHN8E6o9wZGE0dN4R5uK3cyHbpWCiatxSqeSNTQ/132, createdBy=eaca1651997, createdName=1ddccb01m45(暂无匿称), createdTime=Sun Jun 06 07:04:36 CST 2021, time=2021-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236390, encodeId=f7111236390f0, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科 经验分享：最近刚接收一篇，审稿周期2月，审稿意见也很专业，对统计方面要求很高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=870, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/55fdd2926f3844a58e02901f47326051/cd164ae797d549e8b5cdc9ed790bc1b5.jpg, createdBy=59502040784, createdName=sur_wu, createdTime=Wed Aug 03 16:43:41 CST 2022, time=2022-08-03, status=1, ipAttribution=)]

2024-11-18 ms9000001085107463 来自贵州省

偏重的研究方向：公共卫生
经验分享：记录一下
In Quality Control 11-03-2024
Under Review 11-14-2024
Review Complete - Decision Processed 11-15-2024

78 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2261492, encodeId=a0f4226149232, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：难啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d899606138, createdName=ms6000000839895533, createdTime=Tue Apr 22 00:22:39 CST 2025, time=2025-04-22, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2259521, encodeId=4c842259521f5, content=拒稿 Start Date Review Complete - Decision Processed 04-07-2025 09:27 Under Review 03-31-2025 14:41 In Quality Control 03-31-2025 09:20 Submission Pending 03-30-2025 23:00, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0c7a5682566, createdName=ms1000001393535737, createdTime=Mon Apr 07 22:29:10 CST 2025, time=2025-04-07, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2254004, encodeId=09b122540047c, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：健康公平 经验分享：焦急等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97486435543, createdName=1057541_1346, createdTime=Fri Feb 28 12:17:25 CST 2025, time=2025-02-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2257627, encodeId=5141225e6274b, content=偏重的研究方向：公共卫生;运动康复 经验分享：In Quality Control 3.24 Under Review 3.25, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34be9276683, createdName=ms8000000722006726, createdTime=Tue Mar 25 10:53:00 CST 2025, time=2025-03-25, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2254908, encodeId=f47b225490846, content=问一下投过的大神们，外科的东西能投这个刊吗？不知道投jama surgery还是这个好中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=618e8608174, createdName=ms4000001428066077, createdTime=Thu Mar 06 18:18:42 CST 2025, time=2025-03-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2230384, encodeId=e1ca223038479, content=偏重的研究方向：公共卫生 经验分享：10-7 submission pending, in quality control, under review 感觉自己写的很差，开个帖记录一下多久会被拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea339149238, createdName=ms7000000384438036, createdTime=Fri Oct 11 20:37:08 CST 2024, time=2024-10-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1231654, encodeId=02ab1231654ab, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：We agree to consider your manuscript with the understanding that its content, figures, and tables have not been published or submitted elsewhere in print or electronic format and will not be submitted elsewhere during the period of review by JAMA Network Open. 这个邮件发过来是送外审的意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=615, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=66e85489884, createdName=ms6000000512079400, createdTime=Sun Jul 10 15:33:48 CST 2022, time=2022-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2237621, encodeId=364e223e621d2, content=偏重的研究方向：公共卫生 经验分享：记录一下 In Quality Control 11-03-2024 Under Review 11-14-2024 Review Complete - Decision Processed 11-15-2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00ca9170328, createdName=ms9000001085107463, createdTime=Mon Nov 18 16:36:31 CST 2024, time=2024-11-18, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=971239, encodeId=7dd09e1239e2, content=在jama c a r d iol o g y子刊上投了一篇，很快拒稿然后根据我的要求转投ja ma network op en杂志，希望有好结果！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=953, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IRJ7eO6DmdWicRgxO6ka2BZ4CAeEMy8ZKWIfz7TDKA1ibzKutMicHN8E6o9wZGE0dN4R5uK3cyHbpWCiatxSqeSNTQ/132, createdBy=eaca1651997, createdName=1ddccb01m45(暂无匿称), createdTime=Sun Jun 06 07:04:36 CST 2021, time=2021-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236390, encodeId=f7111236390f0, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科 经验分享：最近刚接收一篇，审稿周期2月，审稿意见也很专业，对统计方面要求很高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=870, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/55fdd2926f3844a58e02901f47326051/cd164ae797d549e8b5cdc9ed790bc1b5.jpg, createdBy=59502040784, createdName=sur_wu, createdTime=Wed Aug 03 16:43:41 CST 2022, time=2022-08-03, status=1, ipAttribution=)]

2021-06-06 1ddccb01m45(暂无匿称)

在jama c a r d iol o g y子刊上投了一篇，很快拒稿然后根据我的要求转投ja ma network op en杂志，希望有好结果！

953 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2261492, encodeId=a0f4226149232, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：难啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d899606138, createdName=ms6000000839895533, createdTime=Tue Apr 22 00:22:39 CST 2025, time=2025-04-22, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2259521, encodeId=4c842259521f5, content=拒稿 Start Date Review Complete - Decision Processed 04-07-2025 09:27 Under Review 03-31-2025 14:41 In Quality Control 03-31-2025 09:20 Submission Pending 03-30-2025 23:00, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0c7a5682566, createdName=ms1000001393535737, createdTime=Mon Apr 07 22:29:10 CST 2025, time=2025-04-07, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2254004, encodeId=09b122540047c, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：健康公平 经验分享：焦急等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97486435543, createdName=1057541_1346, createdTime=Fri Feb 28 12:17:25 CST 2025, time=2025-02-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2257627, encodeId=5141225e6274b, content=偏重的研究方向：公共卫生;运动康复 经验分享：In Quality Control 3.24 Under Review 3.25, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34be9276683, createdName=ms8000000722006726, createdTime=Tue Mar 25 10:53:00 CST 2025, time=2025-03-25, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2254908, encodeId=f47b225490846, content=问一下投过的大神们，外科的东西能投这个刊吗？不知道投jama surgery还是这个好中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=618e8608174, createdName=ms4000001428066077, createdTime=Thu Mar 06 18:18:42 CST 2025, time=2025-03-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2230384, encodeId=e1ca223038479, content=偏重的研究方向：公共卫生 经验分享：10-7 submission pending, in quality control, under review 感觉自己写的很差，开个帖记录一下多久会被拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea339149238, createdName=ms7000000384438036, createdTime=Fri Oct 11 20:37:08 CST 2024, time=2024-10-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1231654, encodeId=02ab1231654ab, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：We agree to consider your manuscript with the understanding that its content, figures, and tables have not been published or submitted elsewhere in print or electronic format and will not be submitted elsewhere during the period of review by JAMA Network Open. 这个邮件发过来是送外审的意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=615, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=66e85489884, createdName=ms6000000512079400, createdTime=Sun Jul 10 15:33:48 CST 2022, time=2022-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2237621, encodeId=364e223e621d2, content=偏重的研究方向：公共卫生 经验分享：记录一下 In Quality Control 11-03-2024 Under Review 11-14-2024 Review Complete - Decision Processed 11-15-2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00ca9170328, createdName=ms9000001085107463, createdTime=Mon Nov 18 16:36:31 CST 2024, time=2024-11-18, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=971239, encodeId=7dd09e1239e2, content=在jama c a r d iol o g y子刊上投了一篇，很快拒稿然后根据我的要求转投ja ma network op en杂志，希望有好结果！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=953, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IRJ7eO6DmdWicRgxO6ka2BZ4CAeEMy8ZKWIfz7TDKA1ibzKutMicHN8E6o9wZGE0dN4R5uK3cyHbpWCiatxSqeSNTQ/132, createdBy=eaca1651997, createdName=1ddccb01m45(暂无匿称), createdTime=Sun Jun 06 07:04:36 CST 2021, time=2021-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236390, encodeId=f7111236390f0, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科 经验分享：最近刚接收一篇，审稿周期2月，审稿意见也很专业，对统计方面要求很高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=870, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/55fdd2926f3844a58e02901f47326051/cd164ae797d549e8b5cdc9ed790bc1b5.jpg, createdBy=59502040784, createdName=sur_wu, createdTime=Wed Aug 03 16:43:41 CST 2022, time=2022-08-03, status=1, ipAttribution=)]

2022-08-03 sur_wu

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：外科
经验分享：最近刚接收一篇，审稿周期2月，审稿意见也很专业，对统计方面要求很高

870 12

展开12条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务